All News
Filter News
Found 808,940 articles
-
Arthritis Foundation Kicks Off Arthritis Awareness Month with Release of Key Findings from Patient Study, Announces Launch of New App
5/3/2021
The Arthritis Foundation, the nation's leading organization dedicated to improving the lives of the over 54 million people in the United States living with arthritis, released results of its How it Hurts report – one of the most comprehensive collections of data from people with arthritis ever conducted.
-
New members elected to Occlutech Board of Directors
5/3/2021
Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board
-
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 03, 2021
5/3/2021
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, announced that on April 30, 2021, the Company granted stock options to seven new employees of the Company.
-
Dyadic to Present at Upcoming Events - May 03, 2021
5/3/2021
Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, announced that the Company will participate in the following upcoming events
-
The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence
5/3/2021
Camurus AB announced that the Australian regulatory agency, the Therapeutic Goods Administration, has approved key label updates to Buvidal® Weekly and Buvidal® Monthly modified-release solutions for injection.
-
Relay Therapeutics Expands Clinical Leadership Team with Addition of Tara O’Meara and Charles Ferté
5/3/2021
Ms. O’Meara and Dr. Ferté bring extensive experience in drug development across oncology and genetic disease
-
Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
5/3/2021
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced preliminary financial results for the first quarter of 2021.
-
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2021
5/3/2021
Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it has granted non-statutory stock options to purchase an aggregate of 15,000 ordinary shares of Nabriva Therapeutics as an inducement to two newly-hired employees.
-
Baxter Increases Dividend and Declares Quarterly Dividend - May 03, 2021
5/3/2021
Baxter International Inc., a leading global medical products company, announced an increase in the company’s quarterly cash dividend to a rate of $0.28 per share of common stock.
-
GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASH
5/3/2021
Lille, France; Cambridge, MA;May 3, 2021 - GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, announced the launch of NASHnext®, a novel, noninvasive diagnostic test for nonalcoholic steatohepatitis.
-
RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan)
5/3/2021
Professor Tsukasa Kumai, member of the Japan's Olympic Committee Medical and Scientific Staff, will lead RepliCel's Tendon Regeneration Clinical Testing in Japan
-
The Aesthetic Surgery Education And Research Foundation Elects Louis L. Strock, MD As Its New President
5/3/2021
The Aesthetic Surgery Education and Research Foundation announced the election of Louis L. Strock, MD, a plastic surgeon practicing in Fort Worth, Texas as its new President.
-
Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy
5/3/2021
Masimo announced the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall d’Hebron University Hospital in Barcelona evaluated the utility of Masimo PVi® as a noninvasive method of predicting preload responsiveness in patients treated with nasal high-flow therapy.
-
Syneos Health Announces Secondary Offering of Common Stock - May 03, 2021
5/3/2021
Syneos Health, Inc., the only fully integrated biopharmaceutical solutions organization, announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 7,000,000 shares of the Company’s common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission.
-
Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics
5/3/2021
Sonnet BioTherapeutics Holdings, Inc., a biopharmaceutical company developing innovative targeted biologic drugs, announced that it has executed a definitive agreement with New Life Therapeutics Pte. Ltd. of Singapore for the license of low-dose Interleukin 6, or IL-6, for the treatment of Diabetic Peripheral Neuropathy.
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2021
5/3/2021
Cytokinetics, Incorporated announced that on April 30, 2021 it granted stock options to purchase an aggregate of 69,800 shares of common stock to six new employees whose employment commenced in April 2021 as a material inducement to their employment.
-
Align Technology Announces $100 Million Accelerated Stock Repurchase Program
5/3/2021
Align Technology, Inc. announced that it has entered into an accelerated stock repurchase agreement with Goldman Sachs & Co LLC, to repurchase $100 million of Align's common stock to complete its $600 million stock repurchase program announced on May 23, 2018.
-
Medline Healthcare Resilience Initiative Invests $1.5 Billion into Long-Term Future of U.S. Healthcare Supply Chain
5/3/2021
Medline announced the results of a three-year national capital expenditure campaign to support the long-term needs of healthcare providers that included $1.5 billion in new distribution centers, manufacturing capabilities and IT upgrades for an improved ecommerce experience.
-
Advanced Dermatology and Cosmetic Surgery and SciBase team up to raise awareness of skin cancer
5/3/2021
SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders, announced , on "Melanoma Monday", their joint efforts with Advanced Dermatology and Cosmetic Surgery - the premier dermatology network in the US with over 150 practices - to raise awareness of melanoma and educate around the dangers of the fastest growing and most deadly form of skin cancer to commemorate Skin Cancer Awareness Month.
-
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
5/3/2021
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced an agreement with Gavi, the Vaccine Alliance to supply up to 500 million doses of the COVID-19 Vaccine Moderna, including an initial 34 million doses to be delivered in the fourth quarter of 2021.